Manufacturer has reported 2 presentations are available, and three have limited availability
It does not indicate a different chemical compound, formulation, or variation of tirzepatide
Other notable adverse effects include: Injection site reactions : Mild erythema, itching, or swelling at the subcutaneous injection site Hypoglycaemia : Particularly when tirzepatide is used in combination with insulin or sulphonylureas
Other rows cover insulin resistance status, dietary adherence, gastrointestinal tolerance, and prior weight-loss attempts, with repeated dieting said to increase metabolic adaptation
however, no significant difference was observed in cardiovascular event rates across stages